Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, costing approximately $239.9 billion in 2019 alone due…
medical research
Over the last 12 months, Revive Therapeutics (RVV.C) stock slipped 88% from $0.26 per share to a measly $0.03, but is Revive down for the count? Some analysts believe…
The U.S. Drug Enforcement Agency (D.E.A.) says it will be “moving forward to facilitate and expand scientific and medical research for marijuana,” allowing for additional federally-permitted cannabis cultivators. Despite…